跳至主要内容
临床试验/CTRI/2022/04/041679
CTRI/2022/04/041679已完成未知

To study efficacy and safety of hair serum containing Greyverse, Euk 134 and Amisol trio in premature greying of hair

Apex laboratories private limited0 个研究点目标入组 10 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
已完成
入组人数
10

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1.Patients aged less than 25 years diagnosed with premature canities attending the OPD
  • 2.Patients who are willing to appear for regular follow ups and follow the prescribed treatment regularly.
  • 3.Parents/guardians (legally authorized representative [LAR]) willing to provide written informed consent for patients aged less than 18 years. Patients between 18-25 years of age willing to provide written informed consent

排除标准

  • 1.Patients known to be allergic to any of the components of the study medications.
  • 2.History of any chronic systemic disease
  • 3.Patients with known malignancy or those on chemotherapy.
  • 4.Refusal to participate in the study.
  • 5.Participated in a clinical trial in last 90 days

研究者

相似试验